Rasilez – Innovative Treatment for Hypertension


Many patients have overlapping risk factors. Among the hypertension population, about two-thirds have dyslipidaemia, while almost half are overweight and a fifth have type 2 diabetes.



| 1 | 2 | 3 | 4 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development